Moolec Science (MLECW) Total Debt (2022 - 2025)
Moolec Science (MLECW) posted Total Debt of $228.5 million for Q2 2025, up 489.77% sequentially from $38.7 million in Q4 2024, and down 36.84% YoY from $361.8 million in Q2 2024.
Moolec Science (MLECW) Total Debt (2022 - 2025) Analysis & Trends
Moolec Science has reported Total Debt for 4 years, with the latest figure at $228.5 million in Q2 2025.
- Quarterly Total Debt fell 36.84% year-over-year to $228.5 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $228.5 million (down 36.84% YoY) and the FY2025 annual result came in at $228.5 million, down 36.84% from the prior year.
- Total Debt climbed to $228.5 million in Q2 2025 per MLECW's latest filing, from $38.7 million in the prior quarter.
- Over five years, Total Debt peaked at $361.8 million in Q2 2024 and troughed at $1171.0 in Q2 2022.
- A 4-year average of $62.9 million and a median of $13.5 million in 2023 frame the typical range for Total Debt.
- The sharpest annual moves came in 2023 and 2025: Total Debt jumped 1240899.4% in 2023, then sank 36.84% in 2025.
- Over 4 years, Total Debt stood at $838117.0 in 2022, then jumped by 1506.42% to $13.5 million in 2023, then soared by 187.77% to $38.7 million in 2024, then jumped by 489.77% to $228.5 million in 2025.
- According to Business Quant data, Total Debt over the past three periods registered $228.5 million, $38.7 million, and $18.2 million for Q2 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 9.34 Bn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 228.50 Mn |
| Dec 31, 2024 | 38.74 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 361.76 Mn |
| Mar 31, 2024 | 10.61 Mn |
| Dec 31, 2023 | 13.46 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 14.53 Mn |
| Mar 31, 2023 | 2.35 Mn |
| Dec 31, 2022 | 838,117.00 |
| Jun 30, 2022 | 1,171.00 |